A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer S Liu, S Kumari, Q Hu, D Senapati, VB Venkadakrishnan, D Wang, ... Elife 6, e28482, 2017 | 69 | 2017 |
Comparative proteomic analyses of avirulent, virulent, and clinical strains of Mycobacterium tuberculosis identify strain-specific patterns GD Jhingan, S Kumari, SV Jamwal, H Kalam, D Arora, N Jain, LK Kumaar, ... Journal of Biological Chemistry 291 (27), 14257-14273, 2016 | 43 | 2016 |
Androgen receptor co-regulation in prostate cancer D Senapati, S Kumari, HV Heemers Asian Journal of Urology 7 (3), 219-232, 2020 | 36 | 2020 |
Therapeutic potential of p53 reactivation in prostate cancer: Strategies and opportunities S Kumari, V Sharma, R Tiwari, JP Maurya, BB Subudhi, D Senapati European Journal of Pharmacology 919, 174807, 2022 | 22 | 2022 |
Rationale for the development of alternative forms of androgen deprivation therapy S Kumari, D Senapati, HV Heemers Endocrine-related cancer 24 (8), R275-R295, 2017 | 17 | 2017 |
Pregnane and Xenobiotic Receptor gene expression in liver cells is modulated by Ets-1 in synchrony with transcription factors Pax5, LEF-1 and c-Jun S Kumari, M Saradhi, M Rana, S Chatterjee, M Aumercier, ... Experimental cell research 330 (2), 398-411, 2015 | 12 | 2015 |
Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy VB Venkadakrishnan, AD DePriest, S Kumari, D Senapati, S Ben-Salem, ... Oncogene 38 (23), 4496-4511, 2019 | 11 | 2019 |
"Go", "No Go," or "Where to Go"; does microbiota dictate T cell exhaustion, programming, and HIV persistence? AAS Sudhanshu Shukla 1, Sangeeta Kumari, Saswat K Bal, Daniela C Monaco ... Curr Opin HIV AIDS, 2021 | 9 | 2021 |
Diversity in androgen receptor action among treatment-naïve prostate cancers is reflected in treatment response predictions and molecular subtypes S Ben-Salem, Q Hu, Y Liu, M Alshalalfa, X Zhao, I Wang, ... European urology open science 22, 34-44, 2020 | 9 | 2020 |
Identification and interplay of sequence specific DNA binding proteins involved in regulation of human Pregnane and Xenobiotic Receptor gene M Saradhi, S Kumari, M Rana, G Mukhopadhyay, RK Tyagi Experimental Cell Research 339 (2), 187-196, 2015 | 7 | 2015 |
Transcriptional regulation of mouse PXR gene: an interplay of transregulatory factors S Kumari, G Mukhopadhyay, RK Tyagi Public Library of Science 7 (8), e44126, 2012 | 7 | 2012 |
Inhibition of Protein Kinase N1 prevents control of AR over SRF action in advanced prostate cancer VB Venkadarkrishnan, A DePriest, Y Su, G Mudduluru, S Ben-Salem, ... Cancer Research 78 (13_Supplement), 3745-3745, 2018 | | 2018 |
Androgen receptor action in prostate cancer partitions into distinct transcriptional codes that differ in clinical relevance S Kumari, VB Venkadakrishnan, D Senapati, Q Hu, S Liu, HV Heemers Cancer Research 77 (13_Supplement), 1581-1581, 2017 | | 2017 |
Isolation of WDR77-mediated interaction between androgen receptor and p53 uncovers novel treatment strategy for prostate cancer S Kumari, S Schlanger, D Wang, S Liu, H Heemers Cancer Research 76 (14_Supplement), 865-865, 2016 | | 2016 |
Stable integration of a xenobiotic receptor promoter-reporter DNA construct into a human liver cell line for evaluating the drugs by high throughput screening. SMMG Tyagi RK, Negi S, Kumari S WO Patent WO/2011/108,003, 2011 | | 2011 |